Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Lung Neoplasms 18Hematologic Neoplasms 10Prostatic Neoplasms 9Colorectal Neoplasms 9Breast Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 8Carcinoma, Non-Small-Cell Lung 7Anatomic Stage I Breast Cancer AJCC v8 7Pancreatic Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Neoplasms 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Carcinoma 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Multiple Myeloma 3Melanoma 3Malignant Solid Neoplasm 3Lymphoma 3Leukemia, Myeloid, Acute 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Mouth Neoplasms 2Head and Neck Neoplasms 2

Interventions

Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Salpingo-oophorectomy 1Salpingectomy 1Practice Guidelines as Topic 1Ovariectomy 1Methods 1High-Throughput Nucleotide Sequencing 1Genotype 1Genetic Testing 1Genetic Counseling 1Counseling 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Breast and Ovarian Cancer Syndrome × Practice Guidelines as Topic × 1 year × Clear all
NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡